Barclays »

Ani Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $935k 719k 1.30

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Ani Pharmaceuticals

Point72 Asset Management
Citadel Advisors
Camden Asset Management
Alberta Investment Management Corporation
Empyrean Capital Partners
HBK Investments
BlackRock
Absolute Investment Advisers
Readystate Asset Management
Jpmorgan Chase & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
Goldman Sachs Group
Nykredit A/S
Gabelli Funds
FMR

View all funds holding Ani Pharmaceuticals